Interview with Guldem Berkman, President, AIFD – Association of…
Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our…
Address: Buyukdere Cad. No:185 Kanyon Ofis Blogu Kat:4,Levent Istanbul 34394 Turkey
Tel: +90 (212) 353 11 20
IEIS was established in 1964 to improve and bolster business conditions of its members and to contribute to the development of healthcare policies in Turkey
– Carrying on activities with the mission to make the Turkish pharmaceutical industry a global player and a leading drug manufacturer in the world
– Facilitating the functioning of and providing services to the Turkish Pharmaceutical Exporters Platform which was set up to increase the international competitiveness of the industry.
– Compiling and publishing industrial data as well as health statistics.
– Representing the Turkish pharmaceutical industry in international – Developing policies to ensure progress in the Turkish pharmaceutical industry and maintain a healthy competitive environment in the market.
– Cooperating with public and academic institutions and other NGOs to support R&D activities in the industry.
– Working towards sustaining high level of ethical standards in the industry.
– Mobilizing and coordinating the industry for providing medicines to domestic and international relief agencies when needed.G368
Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our…
Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the generic penetration is much lower…
Currently, what are the main priorities and goals of ISPAT related to the Healthcare and Pharmaceuticals sector, and what are the overall strategies designed to achieve these objectives? As an…
What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is always challenging…
Can you describe the current investment climate in Turkey for pharma companies? Turkey’s economic and political situation are very important factors to consider for foreign investors. Over the last three…
Mr. Ediz Günsel, could you introduce yourself to our readers ? Yes; I have been with the firm over twenty years, including 5 years with PwC London. In my twenty…
At Reckitt Benckiser, you have gradually taken positions of increasing responsibility over the last decade in Marketing. What would you highlight as the main specificities of Turkish market compared to…
The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General Manager of Ferring Turkey over those last 7 years. Can you…
Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it positions itself in…
You have pharmaceuticals production in your background and have recently joined PharmaVision as General Manager. To what extent does this speak about the company’s direction? Could you elaborate on your…
Mr Fadıllıoğlu, after a previous position at Abbott, you were recently appointed head of GSK Turkey. How different is GSK as an organization? What new therapeutic areas, processes, or corporate…
Mr Acar, could you present to our readers the Institution’s historical development and its role today in the Turkish pharmaceutical and healthcare sector? Before Social Security Reform was initiated, there…
See our Cookie Privacy Policy Here
